Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Less than half of the 26,000 annual rhabdomyolysis cases in the United States are exercise-related, but early recognition remains crucial for preventing severe complications.
Emergency Medicine October 23rd 2024
The New England Journal of Medicine
The study reveals that 10% of patients treated with eli-cel developed hematologic cancer, with an incidence rate of 2.1 per 100 person-years. This finding emphasizes the need for careful monitoring and risk assessment in gene therapy approaches.
Hematology/Oncology October 17th 2024
AL amyloidosis can present with distinctive periorbital signs, including petechiae and waxy eyelid papules, which may worsen with trauma.
Dermatology August 26th 2024
Medical Xpress
Yale researchers have developed an AI model capable of diagnosing Marfan syndrome from facial photographs with 98.5% accuracy, potentially enabling earlier intervention for this life-threatening genetic disorder.
Cardiology August 21st 2024
Epoch Health
The Social Security Administration’s expansion of the Compassionate Allowances program now covers 287 severe health conditions, streamlining the disability benefits process for patients with urgent medical needs.
Neurology August 20th 2024
In a phase 3 trial, oral sebetralstat demonstrated a median time to beginning of symptom relief of 1.61 hours for the 300 mg dose and 1.79 hours for the 600 mg dose, compared to 6.72 hours for placebo in hereditary angioedema attacks.
Allergy & Immunology August 16th 2024